Global PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size, Status and Forecast 2020-2026
Table of Contents1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by PARP (Poly ADP-ribose Polymerase) Inhibitors Revenue
1.4 Market Analysis by Type
1.4.1 Global PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Olaparib
1.4.3 Talazoparib
1.5 Market by Application
1.5.1 Global PARP (Poly ADP-ribose Polymerase) Inhibitors Market Share by Application: 2020 VS 2026
1.5.2 Ovarian Cancer
1.5.3 Breast Cancer
1.5.4 Other
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends by Regions
2.1 PARP (Poly ADP-ribose Polymerase) Inhibitors Market Perspective (2015-2026)
2.2 PARP (Poly ADP-ribose Polymerase) Inhibitors Growth Trends by Regions
2.2.1 PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 PARP (Poly ADP-ribose Polymerase) Inhibitors Historic Market Share by Regions (2015-2020)
2.2.3 PARP (Poly ADP-ribose Polymerase) Inhibitors Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter's Five Forces Analysis
2.3.5 PARP (Poly ADP-ribose Polymerase) Inhibitors Market Growth Strategy
2.3.6 Primary Interviews with Key PARP (Poly ADP-ribose Polymerase) Inhibitors Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top PARP (Poly ADP-ribose Polymerase) Inhibitors Players by Market Size
3.1.1 Global Top PARP (Poly ADP-ribose Polymerase) Inhibitors Players by Revenue (2015-2020)
3.1.2 Global PARP (Poly ADP-ribose Polymerase) Inhibitors Revenue Market Share by Players (2015-2020)
3.1.3 Global PARP (Poly ADP-ribose Polymerase) Inhibitors Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global PARP (Poly ADP-ribose Polymerase) Inhibitors Market Concentration Ratio
3.2.1 Global PARP (Poly ADP-ribose Polymerase) Inhibitors Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by PARP (Poly ADP-ribose Polymerase) Inhibitors Revenue in 2019
3.3 PARP (Poly ADP-ribose Polymerase) Inhibitors Key Players Head office and Area Served
3.4 Key Players PARP (Poly ADP-ribose Polymerase) Inhibitors Product Solution and Service
3.5 Date of Enter into PARP (Poly ADP-ribose Polymerase) Inhibitors Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2015-2026)
4.1 Global PARP (Poly ADP-ribose Polymerase) Inhibitors Historic Market Size by Type (2015-2020)
4.2 Global PARP (Poly ADP-ribose Polymerase) Inhibitors Forecasted Market Size by Type (2021-2026)
5 PARP (Poly ADP-ribose Polymerase) Inhibitors Breakdown Data by Application (2015-2026)
5.1 Global PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Application (2015-2020)
5.2 Global PARP (Poly ADP-ribose Polymerase) Inhibitors Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size (2015-2020)
6.2 PARP (Poly ADP-ribose Polymerase) Inhibitors Key Players in North America (2019-2020)
6.3 North America PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Type (2015-2020)
6.4 North America PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Application (2015-2020)
7 Europe
7.1 Europe PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size (2015-2020)
7.2 PARP (Poly ADP-ribose Polymerase) Inhibitors Key Players in Europe (2019-2020)
7.3 Europe PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Type (2015-2020)
7.4 Europe PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Application (2015-2020)
8 China
8.1 China PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size (2015-2020)
8.2 PARP (Poly ADP-ribose Polymerase) Inhibitors Key Players in China (2019-2020)
8.3 China PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Type (2015-2020)
8.4 China PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Application (2015-2020)
9 Japan
9.1 Japan PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size (2015-2020)
9.2 PARP (Poly ADP-ribose Polymerase) Inhibitors Key Players in Japan (2019-2020)
9.3 Japan PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Type (2015-2020)
9.4 Japan PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size (2015-2020)
10.2 PARP (Poly ADP-ribose Polymerase) Inhibitors Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Type (2015-2020)
10.4 Southeast Asia PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Application (2015-2020)
11 India
11.1 India PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size (2015-2020)
11.2 PARP (Poly ADP-ribose Polymerase) Inhibitors Key Players in India (2019-2020)
11.3 India PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Type (2015-2020)
11.4 India PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size (2015-2020)
12.2 PARP (Poly ADP-ribose Polymerase) Inhibitors Key Players in Central & South America (2019-2020)
12.3 Central & South America PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Type (2015-2020)
12.4 Central & South America PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Application (2015-2020)
13Key Players Profiles
13.1 AbbVie
13.1.1 AbbVie Company Details
13.1.2 AbbVie Business Overview and Its Total Revenue
13.1.3 AbbVie PARP (Poly ADP-ribose Polymerase) Inhibitors Introduction
13.1.4 AbbVie Revenue in PARP (Poly ADP-ribose Polymerase) Inhibitors Business (2015-2020))
13.1.5 AbbVie Recent Development
13.2 Pfizer
13.2.1 Pfizer Company Details
13.2.2 Pfizer Business Overview and Its Total Revenue
13.2.3 Pfizer PARP (Poly ADP-ribose Polymerase) Inhibitors Introduction
13.2.4 Pfizer Revenue in PARP (Poly ADP-ribose Polymerase) Inhibitors Business (2015-2020)
13.2.5 Pfizer Recent Development
13.3 AstraZeneca
13.3.1 AstraZeneca Company Details
13.3.2 AstraZeneca Business Overview and Its Total Revenue
13.3.3 AstraZeneca PARP (Poly ADP-ribose Polymerase) Inhibitors Introduction
13.3.4 AstraZeneca Revenue in PARP (Poly ADP-ribose Polymerase) Inhibitors Business (2015-2020)
13.3.5 AstraZeneca Recent Development
13.4 GlaxoSmithKline
13.4.1 GlaxoSmithKline Company Details
13.4.2 GlaxoSmithKline Business Overview and Its Total Revenue
13.4.3 GlaxoSmithKline PARP (Poly ADP-ribose Polymerase) Inhibitors Introduction
13.4.4 GlaxoSmithKline Revenue in PARP (Poly ADP-ribose Polymerase) Inhibitors Business (2015-2020)
13.4.5 GlaxoSmithKline Recent Development
13.5 Clovis Oncology
13.5.1 Clovis Oncology Company Details
13.5.2 Clovis Oncology Business Overview and Its Total Revenue
13.5.3 Clovis Oncology PARP (Poly ADP-ribose Polymerase) Inhibitors Introduction
13.5.4 Clovis Oncology Revenue in PARP (Poly ADP-ribose Polymerase) Inhibitors Business (2015-2020)
13.5.5 Clovis Oncology Recent Development
13.6 Everest Pharmaceuticals
13.6.1 Everest Pharmaceuticals Company Details
13.6.2 Everest Pharmaceuticals Business Overview and Its Total Revenue
13.6.3 Everest Pharmaceuticals PARP (Poly ADP-ribose Polymerase) Inhibitors Introduction
13.6.4 Everest Pharmaceuticals Revenue in PARP (Poly ADP-ribose Polymerase) Inhibitors Business (2015-2020)
13.6.5 Everest Pharmaceuticals Recent Development
14Analyst's Viewpoints/Conclusions
15Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
List of TablesTable 1. PARP (Poly ADP-ribose Polymerase) Inhibitors Key Market Segments
Table 2. Key Players Covered: Ranking by PARP (Poly ADP-ribose Polymerase) Inhibitors Revenue
Table 3. Ranking of Global Top PARP (Poly ADP-ribose Polymerase) Inhibitors Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Olaparib
Table 6. Key Players of Talazoparib
Table 7. Global PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 8. Global PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Regions (US$ Million): 2020 VS 2026
Table 9. Global PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Regions (2015-2020) (US$ Million)
Table 10. Global PARP (Poly ADP-ribose Polymerase) Inhibitors Market Share by Regions (2015-2020)
Table 11. Global PARP (Poly ADP-ribose Polymerase) Inhibitors Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 12. Global PARP (Poly ADP-ribose Polymerase) Inhibitors Market Share by Regions (2021-2026)
Table 13. Market Top Trends
Table 14. Key Drivers: Impact Analysis
Table 15. Key Challenges
Table 16. PARP (Poly ADP-ribose Polymerase) Inhibitors Market Growth Strategy
Table 17. Main Points Interviewed from Key PARP (Poly ADP-ribose Polymerase) Inhibitors Players
Table 18. Global PARP (Poly ADP-ribose Polymerase) Inhibitors Revenue by Players (2015-2020) (Million US$)
Table 19. Global PARP (Poly ADP-ribose Polymerase) Inhibitors Market Share by Players (2015-2020)
Table 20. Global Top PARP (Poly ADP-ribose Polymerase) Inhibitors Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in PARP (Poly ADP-ribose Polymerase) Inhibitors as of 2019)
Table 21. Global PARP (Poly ADP-ribose Polymerase) Inhibitors by Players Market Concentration Ratio (CR5 and HHI)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players PARP (Poly ADP-ribose Polymerase) Inhibitors Product Solution and Service
Table 24. Date of Enter into PARP (Poly ADP-ribose Polymerase) Inhibitors Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Type (2015-2020) (Million US$)
Table 27. Global PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size Share by Type (2015-2020)
Table 28. Global PARP (Poly ADP-ribose Polymerase) Inhibitors Revenue Market Share by Type (2021-2026)
Table 29. Global PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size Share by Application (2015-2020)
Table 30. Global PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Application (2015-2020) (Million US$)
Table 31. Global PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size Share by Application (2021-2026)
Table 32. North America Key Players PARP (Poly ADP-ribose Polymerase) Inhibitors Revenue (2019-2020) (Million US$)
Table 33. North America Key Players PARP (Poly ADP-ribose Polymerase) Inhibitors Market Share (2019-2020)
Table 34. North America PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Type (2015-2020) (Million US$)
Table 35. North America PARP (Poly ADP-ribose Polymerase) Inhibitors Market Share by Type (2015-2020)
Table 36. North America PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Application (2015-2020) (Million US$)
Table 37. North America PARP (Poly ADP-ribose Polymerase) Inhibitors Market Share by Application (2015-2020)
Table 38. Europe Key Players PARP (Poly ADP-ribose Polymerase) Inhibitors Revenue (2019-2020) (Million US$)
Table 39. Europe Key Players PARP (Poly ADP-ribose Polymerase) Inhibitors Market Share (2019-2020)
Table 40. Europe PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Type (2015-2020) (Million US$)
Table 41. Europe PARP (Poly ADP-ribose Polymerase) Inhibitors Market Share by Type (2015-2020)
Table 42. Europe PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Application (2015-2020) (Million US$)
Table 43. Europe PARP (Poly ADP-ribose Polymerase) Inhibitors Market Share by Application (2015-2020)
Table 44. China Key Players PARP (Poly ADP-ribose Polymerase) Inhibitors Revenue (2019-2020) (Million US$)
Table 45. China Key Players PARP (Poly ADP-ribose Polymerase) Inhibitors Market Share (2019-2020)
Table 46. China PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Type (2015-2020) (Million US$)
Table 47. China PARP (Poly ADP-ribose Polymerase) Inhibitors Market Share by Type (2015-2020)
Table 48. China PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Application (2015-2020) (Million US$)
Table 49. China PARP (Poly ADP-ribose Polymerase) Inhibitors Market Share by Application (2015-2020)
Table 50. Japan Key Players PARP (Poly ADP-ribose Polymerase) Inhibitors Revenue (2019-2020) (Million US$)
Table 51. Japan Key Players PARP (Poly ADP-ribose Polymerase) Inhibitors Market Share (2019-2020)
Table 52. Japan PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Type (2015-2020) (Million US$)
Table 53. Japan PARP (Poly ADP-ribose Polymerase) Inhibitors Market Share by Type (2015-2020)
Table 54. Japan PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Application (2015-2020) (Million US$)
Table 55. Japan PARP (Poly ADP-ribose Polymerase) Inhibitors Market Share by Application (2015-2020)
Table 56. Southeast Asia Key Players PARP (Poly ADP-ribose Polymerase) Inhibitors Revenue (2019-2020) (Million US$)
Table 57. Southeast Asia Key Players PARP (Poly ADP-ribose Polymerase) Inhibitors Market Share (2019-2020)
Table 58. Southeast Asia PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Type (2015-2020) (Million US$)
Table 59. Southeast Asia PARP (Poly ADP-ribose Polymerase) Inhibitors Market Share by Type (2015-2020)
Table 60. Southeast Asia PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Application (2015-2020) (Million US$)
Table 61. Southeast Asia PARP (Poly ADP-ribose Polymerase) Inhibitors Market Share by Application (2015-2020)
Table 62. India Key Players PARP (Poly ADP-ribose Polymerase) Inhibitors Revenue (2019-2020) (Million US$)
Table 63. India Key Players PARP (Poly ADP-ribose Polymerase) Inhibitors Market Share (2019-2020)
Table 64. India PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Type (2015-2020) (Million US$)
Table 65. India PARP (Poly ADP-ribose Polymerase) Inhibitors Market Share by Type (2015-2020)
Table 66. India PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Application (2015-2020) (Million US$)
Table 67. India PARP (Poly ADP-ribose Polymerase) Inhibitors Market Share by Application (2015-2020)
Table 68. Central & South America Key Players PARP (Poly ADP-ribose Polymerase) Inhibitors Revenue (2019-2020) (Million US$)
Table 69. Central & South America Key Players PARP (Poly ADP-ribose Polymerase) Inhibitors Market Share (2019-2020)
Table 70. Central & South America PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Type (2015-2020) (Million US$)
Table 71. Central & South America PARP (Poly ADP-ribose Polymerase) Inhibitors Market Share by Type (2015-2020)
Table 72. Central & South America PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size by Application (2015-2020) (Million US$)
Table 73. Central & South America PARP (Poly ADP-ribose Polymerase) Inhibitors Market Share by Application (2015-2020)
Table 74. AbbVie Company Details
Table 75. AbbVie Business Overview
Table 76. AbbVie Product
Table 77. AbbVie Revenue in PARP (Poly ADP-ribose Polymerase) Inhibitors Business (2015-2020) (Million US$)
Table 78. AbbVie Recent Development
Table 79. Pfizer Company Details
Table 80. Pfizer Business Overview
Table 81. Pfizer Product
Table 82. Pfizer Revenue in PARP (Poly ADP-ribose Polymerase) Inhibitors Business (2015-2020) (Million US$)
Table 83. Pfizer Recent Development
Table 84. AstraZeneca Company Details
Table 85. AstraZeneca Business Overview
Table 86. AstraZeneca Product
Table 87. AstraZeneca Revenue in PARP (Poly ADP-ribose Polymerase) Inhibitors Business (2015-2020) (Million US$)
Table 88. AstraZeneca Recent Development
Table 89. GlaxoSmithKline Company Details
Table 90. GlaxoSmithKline Business Overview
Table 91. GlaxoSmithKline Product
Table 92. GlaxoSmithKline Revenue in PARP (Poly ADP-ribose Polymerase) Inhibitors Business (2015-2020) (Million US$)
Table 93. GlaxoSmithKline Recent Development
Table 94. Clovis Oncology Company Details
Table 95. Clovis Oncology Business Overview
Table 96. Clovis Oncology Product
Table 97. Clovis Oncology Revenue in PARP (Poly ADP-ribose Polymerase) Inhibitors Business (2015-2020) (Million US$)
Table 98. Clovis Oncology Recent Development
Table 99. Everest Pharmaceuticals Company Details
Table 100. Everest Pharmaceuticals Business Overview
Table 101. Everest Pharmaceuticals Product
Table 102. Everest Pharmaceuticals Revenue in PARP (Poly ADP-ribose Polymerase) Inhibitors Business (2015-2020) (Million US$)
Table 103. Everest Pharmaceuticals Recent Development
Table 104. Research Programs/Design for This Report
Table 105. Key Data Information from Secondary Sources
Table 106. Key Data Information from Primary Sources
List of FiguresFigure 1. Global PARP (Poly ADP-ribose Polymerase) Inhibitors Market Share by Type: 2020 VS 2026
Figure 2. Olaparib Features
Figure 3. Talazoparib Features
Figure 4. Global PARP (Poly ADP-ribose Polymerase) Inhibitors Market Share by Application: 2020 VS 2026
Figure 5. Ovarian Cancer Case Studies
Figure 6. Breast Cancer Case Studies
Figure 7. Other Case Studies
Figure 8. PARP (Poly ADP-ribose Polymerase) Inhibitors Report Years Considered
Figure 9. Global PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size YoY Growth 2015-2026 (US$ Million)
Figure 10. Global PARP (Poly ADP-ribose Polymerase) Inhibitors Market Share by Regions: 2020 VS 2026
Figure 11. Global PARP (Poly ADP-ribose Polymerase) Inhibitors Market Share by Regions (2021-2026)
Figure 12. Porter's Five Forces Analysis
Figure 13. Global PARP (Poly ADP-ribose Polymerase) Inhibitors Market Share by Players in 2019
Figure 14. Global Top PARP (Poly ADP-ribose Polymerase) Inhibitors Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in PARP (Poly ADP-ribose Polymerase) Inhibitors as of 2019
Figure 15. The Top 10 and 5 Players Market Share by PARP (Poly ADP-ribose Polymerase) Inhibitors Revenue in 2019
Figure 16. North America PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size YoY Growth (2015-2020) (Million US$)
Figure 17. Europe PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. China PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Japan PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Southeast Asia PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. India PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Central & South America PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. AbbVie Total Revenue (US$ Million): 2019 Compared with 2018
Figure 24. AbbVie Revenue Growth Rate in PARP (Poly ADP-ribose Polymerase) Inhibitors Business (2015-2020)
Figure 25. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 26. Pfizer Revenue Growth Rate in PARP (Poly ADP-ribose Polymerase) Inhibitors Business (2015-2020)
Figure 27. AstraZeneca Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. AstraZeneca Revenue Growth Rate in PARP (Poly ADP-ribose Polymerase) Inhibitors Business (2015-2020)
Figure 29. GlaxoSmithKline Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. GlaxoSmithKline Revenue Growth Rate in PARP (Poly ADP-ribose Polymerase) Inhibitors Business (2015-2020)
Figure 31. Clovis Oncology Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. Clovis Oncology Revenue Growth Rate in PARP (Poly ADP-ribose Polymerase) Inhibitors Business (2015-2020)
Figure 33. Everest Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. Everest Pharmaceuticals Revenue Growth Rate in PARP (Poly ADP-ribose Polymerase) Inhibitors Business (2015-2020)
Figure 35. Bottom-up and Top-down Approaches for This Report
Figure 36. Data Triangulation
Figure 37. Key Executives Interviewed